Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Biologics - Quality Biologics for Ensuring Regulatory and Market Sucess

Maharaj Sahib's Biography



Maharaj Sahib, Director, Wockhardt Ltd

Dr. Maharaj Kishen Sahib, Director – Genomics & Biotechnology.
He completed his education from PhD/Biochemistry, C.D.R.I., Luknow, Year 1967; M.Sc/Biochemistry, Aligarh Muslim University, Aligarh, 1964. Before joining Wockhardt Dr. Sahib was Sr. Asst. Director CDRI Lucknow, 1986 to 1991; Scientist, Asst. Director 1971 to 1986.
He was a Visiting Scientist at: NIH, Bethesda, Maryland, USA, 1975-1977; National Institute of Medical Research Mill Hill, London, UK, 1989-1990; Institute Pasteur, Paris France and INSERM, France. 1988-89
He was an Assistant Professor / Lecturer in University of Colorado, School of Medicine, Denver, Colorado, USA, 1970-1971;Banaras Hindu University, Varanasi, 1967-1968.He was a Research Associate at Harvard Medical School, Boston 1968-1970.
Dr Sahib is a recipient of several Awards and Honors like:
Governor of Maharashtra State’s (India) nominee to membership of Management Council & Senate, Dr. Babasaheb Ambedkar Marathwada University, Aurnagabad, Maharashtra
Dr. C.R. Krishnamurty memorial oration award 2000, several awards from Wockhardt
Served as a member Board of Studies:
oIndian Institute of Technology, Mumbai,
oIndian Institute of Science, Mumbai,
oUniversity of Jammu & Kashmir,
oBAM University, Aurangabad,
oMaharashtra Agricultural University, Parbhani,
oM.S. University, Baroda.
oUniversity of Pune
oShivaji University, Kolhapur
oBiotechnology Task Force, Government of Maharashtra,
Developed biopesticide HALT, for which Wockhardt received first DSIR Award for in-house research in biotechnology
He has More than 100 in peer reviewed International Journals and several international patents to his credit.
His Achievements include Started and established Biotechnology Research Center at WOCKHARDT.
Leading R&D Team for successful development of biosimilars/vaccines/fermentation products.Following are examples of some of the products commercialized/pipeline.
Development of biosimilar recombinant human/humanised therapeutic proteins, vaccines, fermentation products:
Insulin (WOSULIN) and its analogs;
Erythropoietin (WEPOX)
Long acting Erythropoietin
Hepatitis B (BIOVAC B)
Interferon alfa 2b
G-CSF and its PEGylated version
Monoclonal antibodies
Combination vaccines: tetravalent,pentavalent and hexavalent vaccine
Statins: lovastatin, etc.



Maharaj Sahib Image

Add to Calendar ▼2014-02-25 00:00:002014-02-25 00:00:00Europe/LondonBiologics - Quality Biologics for Ensuring Regulatory and Market SucessSELECTBIOenquiries@selectbiosciences.com